Intimate partner violence and prescription of potentially addictive drugs: Prospective cohort study of women in the Oslo Health Study

BMJ Open

Volumn 2, Issue 2, 2012, Pages

  Stene, Lise Eilin ^a   Dyb, Grete ^b   Tverdal, Aage ^c   Jacobsen, Geir Wenberg ^a   Schei, Berit ^a,d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Norwegian Centre for Violence and Traumatic Stress Studies   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CENTRAL DEPRESSANT AGENT;

ADULT; ARTICLE; BINOMIAL DISTRIBUTION; CHRONIC PAIN; DRUG DEPENDENCE; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMAN; INTIMATE PARTNER VIOLENCE; MARRIAGE; MENTAL STRESS; MUSCULOSKELETAL PAIN; PARTNER VIOLENCE; PRESCRIPTION; SLEEP DISORDER;

EID: 84860145712     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000614     Document Type: Article

References (37)

1. Campbell JC. Health consequences of intimate partner violence. Lancet 2002;359:1331-6. (Pubitemid 34310643)
2. Nerøien AI, Schei B. Partner violence and health: results from the first national study on violence against women in Norway. Scand J Public Health 2008;36:161-8. (Pubitemid 351359370)
3. Ellsberg M, Jansen H, Heise L, et al; WHO Multi-country Study on Women's Health and Domestic Violence against Women Study Team. Intimate partner violence and women's physical and mental health in the WHO multi-country study on women's health and domestic violence: an observational study. Lancet 2008;371:1165-72. (Pubitemid 351458521)
4. Coker AL, Davis KE, Arias I, et al. Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med 2002;23:260-8. (Pubitemid 36163415)
5. Stene LE, Dyb G, Jacobsen GW, et al. Psychotropic drug use among women exposed to intimate partner violence: a population-based study. Scand J Public Health 2010;38(5 Suppl):88-95.
6. Romans SE, Cohen MM, Forte T, et al. Gender and psychotropic medication use: the role of intimate partner violence. Prev Med 2008;46:615-21.
7. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(Suppl 2):S105-20. (Pubitemid 351682081)
8. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 1999;9(Suppl 6):S399-405. (Pubitemid 30089072)
9. Rønning M, Berg C, Furu K, et al. The Norwegian Prescription Database 2005-2009. Norwegian Institute of Public Health. Report number: 2, 2010.
10. Manchikanti L. National drug control policy and prescription drug abuse: facts and fallacies. Pain Physician 2007;10:399-424. (Pubitemid 46971294)
11. Wuest J, Merritt-Gray M, Lent B, et al. Patterns of medication use among women survivors of intimate partner violence. Can J Public Health 2007;98:460-4.
12. Cole J, Logan TK. Nonmedical use of sedative-hypnotics and opiates among rural and urban women with protective orders. J Addict Dis 2010;29:395-409.
13. Plichta SB. Intimate partner violence and physical health consequences: policy and practice implications. J Interpers Violence 2004;19:1296-323. (Pubitemid 39499035)
14. Yoshihama M, Horrocks J, Kamano S. The role of emotional abuse in intimate partner violence and health among women in Yokohama, Japan. Am J Public Health 2009;99:647-53.
15. Furu K. Establishment of the nationwide Norwegian Prescription Database (NorPD) - new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 2008;18:129-36. (Pubitemid 351859935)
16. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2005. Oslo, 2004.
17. Søgaard AJ, Selmer R, Bjertness E, et al. The Oslo Health Study: the impact of self-selection in a large, population-based survey. Int J Equity Health 2004;3:3.
18. Søgaard AJ, Selmer R. The Oslo Health Study. 2006. http://www.fhi.no/dav/bbb2a86ad7.doc (accessed 12 Sep. 2011).
19. Strand BH, Dalgard OS, Tambs K, et al. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatr 2003;57:113-18. (Pubitemid 36626132)
20. Norwegian Institute of Public Health. 2011. http://www.norpd.no/ Prevalens.aspx (accessed 10 Aug. 2011).
21. Ludermir AB, Lewis G, Valongueiro SA, et al. Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study. Lancet 2010;376:903-10.
22. Simoni-Wastila L. The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med 2000;9:289-97. (Pubitemid 30234953)
23. Brookhart MA, Stürmer T, Glynn RJ, et al. Confounding control in healthcare database research: challenges and potential approaches. Med Care 2010;48(Suppl 6):S114-20.
24. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 2009;20:488-95.
25. Prescott K, Stratton R, Freyer A, et al. Detailed analyses of self-poisoning episodes presenting to a large regional teaching hospital in the UK. Br J Clin Pharmacol 2009;68:260-8.
26. Fenton MC, Keyes KM, Martins SS, et al. The role of a prescription in anxiety medication use, abuse, and dependence. Am J Psychiat 2010;167:1247-53.
27. Devries K, Watts C, Yoshihama M, et al. Violence against women is strongly associated with suicide attempts: evidence from the WHO multi-country study on women's health and domestic violence against women. Soc Sci Med 2011;73:79-86.
28. Pauly V, Frauger E, Pradel V, et al. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse. Drug Alcohol Depend 2011;113:29-36.
29. Bjørner T, Laerum E. Factors associated with high prescribing of benzodiazepines and minor opiates. A survey among general practitioners in Norway. Scand J Prim Health Care 2003;21:115-20. (Pubitemid 36773422)
30. Anthierens S, Habraken H, Petrovic M, et al. The lesser evil? Initiating a benzodiazepine prescription in general practice: a qualitative study on GPs' perspectives. Scand J Prim Health Care 2007;25:214-19. (Pubitemid 350179029)
31. Vevatne T, Selbekk AS, Sand R. [Addictive drugs prescription practice among general practitioners] (In Norwegian). Tidsskr Nor Laegeforen 2010;130:1925-7.
32. Sturza ML, Campbell R. An exploratory study of rape survivors' prescription drug use as a means of coping with sexual assault. Psychol Women Q 2005;29:353-63. (Pubitemid 43061708)
33. Elliott L, Nerney M, Jones T, et al. Barriers to screening for domestic violence. J Gen Intern Med 2002;17:112-16. (Pubitemid 34595459)
34. Wathen CN, MacMillan HL. Interventions for violence against women: scientific review. JAMA 2003;289:589-600. (Pubitemid 37428631)
35. MacMillan HL, Wathen CN, Jamieson E, et al. Screening for intimate partner violence in health care settings: a randomized trial. JAMA 2009;302:493-501.
36. Feder G, Davies RA, Baird K, et al. Identification and Referral to Improve Safety (IRIS) of women experiencing domestic violence with a primary care training and support programme: a cluster randomised controlled trial. Lancet 2011;378:1788-95.
37. Soglin LF, Bauchat J, Soglin DF, et al. Detection of intimate partner violence in a general medicine practice. J Interpers Violence 2009;24:338-48.